RUOLO DELLA MEDICINA NUCLEARE NELLA DIAGNOSI DIFFERENZIALE TRA PATOLOGIA PSICHIATRICA E NEURODEGENERATIVA

1. 1.Ducharme S.. Clinical use of dementia biomarkers to evaluate cognitive deficits in people with primary psychiatric disorders.. Practical Neurology (US). 2024;23(2):40-43. 2024
   Articolo scientificoPractical Neurology (US). 2024;23(2):40-43Cerca su Google Scholar
2. 2.Guedj, Eric, et al. ". EANM procedure guidelines for brain PET imaging using [18 F] FDG, version 3.. European journal of nuclear medicine and molecular imaging (2022): 1-20.. 2022
   Articolo scientificoEuropean journal of nuclear medicine and molecular imaging (2022): 1-20.Leggi il paperCerca versione gratuita
3. 3.Minoshima, Satoshi, et al. ". 18F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies.. Journal of Nuclear Medicine 63.Supplement 1 (2022): 2S-12S.. 2022
   Articolo scientificoJournal of Nuclear Medicine 63.Supplement 1 (2022): 2S-12S.Leggi il PDF gratuito
4. 4.Chapleau, Marianne, et al. ". The role of amyloid PET in imaging neurodegenerative disorders: a review.. Journal of Nuclear Medicine 63.Supplement 1 (2022): 13S-19S.-. 2022
   Articolo scientificoJournal of Nuclear Medicine 63.Supplement 1 (2022): 13S-19S.-Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).